430 related articles for article (PubMed ID: 11163470)
1. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.
Briles DE; Ades E; Paton JC; Sampson JS; Carlone GM; Huebner RC; Virolainen A; Swiatlo E; Hollingshead SK
Infect Immun; 2000 Feb; 68(2):796-800. PubMed ID: 10639448
[TBL] [Abstract][Full Text] [Related]
3. Polysaccharide-based pneumococcal vaccines in the prevention of acute otitis media.
Eskola J
Vaccine; 2000 Dec; 19 Suppl 1():S78-82. PubMed ID: 11163468
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children.
Simell B; Korkeila M; Pursiainen H; Kilpi TM; Käyhty H
J Infect Dis; 2001 Mar; 183(6):887-96. PubMed ID: 11237805
[TBL] [Abstract][Full Text] [Related]
5. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
Rapola S; Jäntti V; Haikala R; Syrjänen R; Carlone GM; Sampson JS; Briles DE; Paton JC; Takala AK; Kilpi TM; Käyhty H
J Infect Dis; 2000 Oct; 182(4):1146-52. PubMed ID: 10979911
[TBL] [Abstract][Full Text] [Related]
6. Mucosal immunization with PsaA protein, using chitosan as a delivery system, increases protection against acute otitis media and invasive infection by Streptococcus pneumoniae.
Xu JH; Dai WJ; Chen B; Fan XY
Scand J Immunol; 2015 Mar; 81(3):177-85. PubMed ID: 25565478
[TBL] [Abstract][Full Text] [Related]
7. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
Sabirov A; Metzger DW
Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
[TBL] [Abstract][Full Text] [Related]
8. Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media.
Habets MN; van Selm S; van Opzeeland FJ; Simonetti E; Hermans PWM; de Jonge MI; Diavatopoulos DA
Vaccine; 2016 Nov; 34(48):5968-5974. PubMed ID: 27771185
[TBL] [Abstract][Full Text] [Related]
9. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
10. Acute otitis media in the era of effective pneumococcal conjugate vaccine: will new pathogens emerge?
Pelton SI
Vaccine; 2000 Dec; 19 Suppl 1():S96-9. PubMed ID: 11163471
[TBL] [Abstract][Full Text] [Related]
11. New vaccines for the prevention of pneumococcal infections.
Käyhty H; Eskola J
Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
[TBL] [Abstract][Full Text] [Related]
12. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
Lu YJ; Forte S; Thompson CM; Anderson PW; Malley R
Infect Immun; 2009 May; 77(5):2076-83. PubMed ID: 19255193
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies.
da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC
Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal otitis media and pneumococcal vaccines, a historical perspective.
Austrian R
Vaccine; 2000 Dec; 19 Suppl 1():S71-7. PubMed ID: 11163467
[TBL] [Abstract][Full Text] [Related]
15. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
[TBL] [Abstract][Full Text] [Related]
16. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.
Prymula R; Kriz P; Kaliskova E; Pascal T; Poolman J; Schuerman L
Vaccine; 2009 Dec; 28(1):71-8. PubMed ID: 19818722
[TBL] [Abstract][Full Text] [Related]
17. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
Lin H; Peng Y; Lin Z; Zhang S; Guo Y
Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
[TBL] [Abstract][Full Text] [Related]
18. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France.
Cohen R; Levy C; Bonnet E; Grondin S; Desvignes V; Lecuyer A; Fritzell B; Varon E
Vaccine; 2010 Aug; 28(37):6114-21. PubMed ID: 19490958
[TBL] [Abstract][Full Text] [Related]
19. Passive immunization for the prevention of otitis media.
Englund JA; Glezen WP
Vaccine; 2000 Dec; 19 Suppl 1():S116-21. PubMed ID: 11163474
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
Hammitt LL; Campbell JC; Borys D; Weatherholtz RC; Reid R; Goklish N; Moulton LH; Traskine M; Song Y; Swinnen K; Santosham M; O'Brien KL
Vaccine; 2019 Dec; 37(51):7482-7492. PubMed ID: 31629570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
